Early findings around GLP-1s and addiction preclinical research suggest: Reduced drug-seeking behaviors in animal models involving opioids, nicotine, and stimulants Possible changes in reward sensitivity and reinforcement mechanisms Overlap between neural pathways involved in appetite regulation and substance use However, translating these findings to human populations has proven challenging
PubMed ID: 9849822 CJC-1295 Without DAC vs Other GHRH-Class Research Peptides CJC-1295 Without DACs unique combination of four stabilising amino acid substitutions, full GHRH receptor selectivity, physiological pulsatile GH release architecture, somatostatin feedback preservation, and ~30-minute half-life makes it the most versatile and broadly applicable pulsatile GHRH-class secretagogue for GH axis research and the defining GHRH component in the most widely studied dual-receptor GH secretagogue combination in pre-clinical literature
"Efficacy of intravenous glutathione vs
Bone broth, collagen peptides, and protein powders also work well as between-meal options
Slow eating amplifies pleasure: take 2030 minutes per meal, chew thoroughly, and engage all senses